Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Chemotherapy-Induced Nausea and Vomiting Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Chemotherapy-Induced Nausea and Vomiting Drugs by Country/Region, 2017, 2022 & 2028

2.2 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type

2.2.1 Existing Drugs

2.2.2 Akynzeo (Netupitant-Palonosetron FDC)

2.2.3 Aloxi (Palonosetron)

2.2.4 Emend (Aprepitant)

2.2.5 Kytril Generic (Granisetron)

2.2.6 Zofran Generic (Ondansetron)

2.2.7 Pipeline Drugs

2.2.8 SUSTOL (Granisetron Injection extended release)

2.2.9 Rolapitant

2.3 Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type

2.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sale Price by Type (2017-2022)

2.4 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application

2.4.1 Serotonin Receptor Antagonists

2.4.2 NK1 Receptor Antagonists

2.5 Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application

2.5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sale Price by Application (2017-2022)

3 Global Chemotherapy-Induced Nausea and Vomiting Drugs by Company

3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Breakdown Data by Company

3.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2020-2022)

3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2020-2022)

3.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sale Price by Company

3.4 Key Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Location Distribution

3.4.2 Players Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Chemotherapy-Induced Nausea and Vomiting Drugs by Geographic Region

4.1 World Historic Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Annual Revenue by Geographic Region

4.2 World Historic Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Annual Revenue by Country/Region

4.3 Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth

4.4 APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth

4.5 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth

4.6 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth

5 Americas

5.1 Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country

5.1.1 Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022)

5.1.2 Americas Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022)

5.2 Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type

5.3 Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region

6.1.1 APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2017-2022)

6.1.2 APAC Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2017-2022)

6.2 APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type

6.3 APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs by Country

7.1.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022)

7.1.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022)

7.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type

7.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs by Country

8.1.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type

8.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs

10.3 Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs

10.4 Industry Chain Structure of Chemotherapy-Induced Nausea and Vomiting Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors

11.3 Chemotherapy-Induced Nausea and Vomiting Drugs Customer

12 World Forecast Review for Chemotherapy-Induced Nausea and Vomiting Drugs by Geographic Region

12.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Forecast by Region

12.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecast by Region (2023-2028)

12.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecast by Type

12.7 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecast by Application

13 Key Players Analysis

13.1 Merck & Co., Inc.

13.1.1 Merck & Co., Inc. Company Information

13.1.2 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

13.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck & Co., Inc. Main Business Overview

13.1.5 Merck & Co., Inc. Latest Developments

13.2 GlaxoSmithKline plc

13.2.1 GlaxoSmithKline plc Company Information

13.2.2 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

13.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline plc Main Business Overview

13.2.5 GlaxoSmithKline plc Latest Developments

13.3 Tesaro, Inc.

13.3.1 Tesaro, Inc. Company Information

13.3.2 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

13.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Tesaro, Inc. Main Business Overview

13.3.5 Tesaro, Inc. Latest Developments

13.4 Helsinn Group

13.4.1 Helsinn Group Company Information

13.4.2 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

13.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Helsinn Group Main Business Overview

13.4.5 Helsinn Group Latest Developments

13.5 F. Hoffmann-La Roche Ltd.

13.5.1 F. Hoffmann-La Roche Ltd. Company Information

13.5.2 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

13.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview

13.5.5 F. Hoffmann-La Roche Ltd. Latest Developments

13.6 Heron Therapeutics, Inc.

13.6.1 Heron Therapeutics, Inc. Company Information

13.6.2 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

13.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Heron Therapeutics, Inc. Main Business Overview

13.6.5 Heron Therapeutics, Inc. Latest Developments

13.7 Dr. Reddy's Laboratories Ltd.

13.7.1 Dr. Reddy's Laboratories Ltd. Company Information

13.7.2 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

13.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Dr. Reddy's Laboratories Ltd. Main Business Overview

13.7.5 Dr. Reddy's Laboratories Ltd. Latest Developments

13.8 Acacia Pharma

13.8.1 Acacia Pharma Company Information

13.8.2 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

13.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Acacia Pharma Main Business Overview

13.8.5 Acacia Pharma Latest Developments

13.9 Sun Pharmaceutical Industry Ltd.

13.9.1 Sun Pharmaceutical Industry Ltd. Company Information

13.9.2 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

13.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sun Pharmaceutical Industry Ltd. Main Business Overview

13.9.5 Sun Pharmaceutical Industry Ltd. Latest Developments

13.10 Otsuka Holdings Co., Ltd.

13.10.1 Otsuka Holdings Co., Ltd. Company Information

13.10.2 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

13.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Otsuka Holdings Co., Ltd. Main Business Overview

13.10.5 Otsuka Holdings Co., Ltd. Latest Developments

14 Research Findings and Conclusion

Table 1. Chemotherapy-Induced Nausea and Vomiting Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Chemotherapy-Induced Nausea and Vomiting Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Existing Drugs

Table 4. Major Players of Akynzeo (Netupitant-Palonosetron FDC)

Table 5. Major Players of Aloxi (Palonosetron)

Table 6. Major Players of Emend (Aprepitant)

Table 7. Major Players of Kytril Generic (Granisetron)

Table 8. Major Players of Zofran Generic (Ondansetron)

Table 9. Major Players of Pipeline Drugs

Table 10. Major Players of SUSTOL (Granisetron Injection extended release)

Table 11. Major Players of Rolapitant

Table 12. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2022) & (K Units)

Table 13. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2022)

Table 14. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2022) & ($ million)

Table 15. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2017-2022)

Table 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2022) & (K Units)

Table 18. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2022)

Table 19. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2022)

Table 20. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2017-2022)

Table 21. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 22. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2020-2022) & (K Units)

Table 23. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2020-2022)

Table 24. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2020-2022) ($ Millions)

Table 25. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2020-2022)

Table 26. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 27. Key Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Producing Area Distribution and Sales Area

Table 28. Players Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered

Table 29. Chemotherapy-Induced Nausea and Vomiting Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 30. New Products and Potential Entrants

Table 31. Mergers & Acquisitions, Expansion

Table 32. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 33. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Geographic Region (2017-2022)

Table 34. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 35. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 36. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 37. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country/Region (2017-2022)

Table 38. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 39. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country/Region (2017-2022)

Table 40. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022) & (K Units)

Table 41. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2017-2022)

Table 42. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 43. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2017-2022)

Table 44. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2022) & (K Units)

Table 45. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2022)

Table 46. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2022) & (K Units)

Table 47. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2022)

Table 48. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2017-2022) & (K Units)

Table 49. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2017-2022)

Table 50. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 51. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2017-2022)

Table 52. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2022) & (K Units)

Table 53. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2022)

Table 54. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2022) & (K Units)

Table 55. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2022)

Table 56. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022) & (K Units)

Table 57. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2017-2022)

Table 58. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 59. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2017-2022)

Table 60. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2022) & (K Units)

Table 61. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2022)

Table 62. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2022) & (K Units)

Table 63. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2022)

Table 64. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022) & (K Units)

Table 65. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2017-2022)

Table 66. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 67. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2017-2022)

Table 68. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2022) & (K Units)

Table 69. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2022)

Table 70. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2022) & (K Units)

Table 71. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2022)

Table 72. Key Market Drivers & Growth Opportunities of Chemotherapy-Induced Nausea and Vomiting Drugs

Table 73. Key Market Challenges & Risks of Chemotherapy-Induced Nausea and Vomiting Drugs

Table 74. Key Industry Trends of Chemotherapy-Induced Nausea and Vomiting Drugs

Table 75. Chemotherapy-Induced Nausea and Vomiting Drugs Raw Material

Table 76. Key Suppliers of Raw Materials

Table 77. Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List

Table 78. Chemotherapy-Induced Nausea and Vomiting Drugs Customer List

Table 79. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 80. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Forecast by Region

Table 81. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 83. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 86. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 87. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 88. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 90. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 91. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 92. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Type (2023-2028)

Table 93. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 94. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 95. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 96. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Application (2023-2028)

Table 97. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 98. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 99. Merck & Co., Inc. Basic Information, Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

Table 101. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Merck & Co., Inc. Main Business

Table 103. Merck & Co., Inc. Latest Developments

Table 104. GlaxoSmithKline plc Basic Information, Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

Table 106. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. GlaxoSmithKline plc Main Business

Table 108. GlaxoSmithKline plc Latest Developments

Table 109. Tesaro, Inc. Basic Information, Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

Table 111. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Tesaro, Inc. Main Business

Table 113. Tesaro, Inc. Latest Developments

Table 114. Helsinn Group Basic Information, Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

Table 116. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Helsinn Group Main Business

Table 118. Helsinn Group Latest Developments

Table 119. F. Hoffmann-La Roche Ltd. Basic Information, Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

Table 121. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. F. Hoffmann-La Roche Ltd. Main Business

Table 123. F. Hoffmann-La Roche Ltd. Latest Developments

Table 124. Heron Therapeutics, Inc. Basic Information, Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

Table 126. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Heron Therapeutics, Inc. Main Business

Table 128. Heron Therapeutics, Inc. Latest Developments

Table 129. Dr. Reddy's Laboratories Ltd. Basic Information, Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

Table 131. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Dr. Reddy's Laboratories Ltd. Main Business

Table 133. Dr. Reddy's Laboratories Ltd. Latest Developments

Table 134. Acacia Pharma Basic Information, Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

Table 136. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Acacia Pharma Main Business

Table 138. Acacia Pharma Latest Developments

Table 139. Sun Pharmaceutical Industry Ltd. Basic Information, Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

Table 141. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Sun Pharmaceutical Industry Ltd. Main Business

Table 143. Sun Pharmaceutical Industry Ltd. Latest Developments

Table 144. Otsuka Holdings Co., Ltd. Basic Information, Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered

Table 146. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. Otsuka Holdings Co., Ltd. Main Business

Table 148. Otsuka Holdings Co., Ltd. Latest Developments

List of Figures

Figure 1. Picture of Chemotherapy-Induced Nausea and Vomiting Drugs

Figure 2. Chemotherapy-Induced Nausea and Vomiting Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Existing Drugs

Figure 10. Product Picture of Akynzeo (Netupitant-Palonosetron FDC)

Figure 11. Product Picture of Aloxi (Palonosetron)

Figure 12. Product Picture of Emend (Aprepitant)

Figure 13. Product Picture of Kytril Generic (Granisetron)

Figure 14. Product Picture of Zofran Generic (Ondansetron)

Figure 15. Product Picture of Pipeline Drugs

Figure 16. Product Picture of SUSTOL (Granisetron Injection extended release)

Figure 17. Product Picture of Rolapitant

Figure 18. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2021

Figure 19. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2017-2022)

Figure 20. Chemotherapy-Induced Nausea and Vomiting Drugs Consumed in Serotonin Receptor Antagonists

Figure 21. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market: Serotonin Receptor Antagonists (2017-2022) & (K Units)

Figure 22. Chemotherapy-Induced Nausea and Vomiting Drugs Consumed in NK1 Receptor Antagonists

Figure 23. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market: NK1 Receptor Antagonists (2017-2022) & (K Units)

Figure 24. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2022)

Figure 25. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application in 2021

Figure 26. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company in 2021

Figure 28. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Geographic Region in 2021

Figure 30. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2017-2022)

Figure 31. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country/Region in 2021

Figure 32. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2017-2022 (K Units)

Figure 33. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Revenue 2017-2022 ($ Millions)

Figure 34. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2017-2022 (K Units)

Figure 35. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2017-2022 (K Units)

Figure 37. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue 2017-2022 ($ Millions)

Figure 40. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country in 2021

Figure 41. Americas Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country in 2021

Figure 42. United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region in 2021

Figure 47. APAC Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Regions in 2021

Figure 48. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country in 2021

Figure 55. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country in 2021

Figure 56. Germany Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country in 2021

Figure 63. Egypt Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs in 2021

Figure 69. Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs

Figure 70. Industry Chain Structure of Chemotherapy-Induced Nausea and Vomiting Drugs

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles